Q3 Earnings Estimate for Humacyte Issued By HC Wainwright
Humacyte, Inc. (NASDAQ:HUMA – Free Report) – Equities researchers at HC Wainwright issued their Q3 2025 EPS estimates for Humacyte in a research note issued on Wednesday, May 14th. HC Wainwright analyst S. Ramakanth anticipates that the company will earn ($0.13) per share for the quarter. HC Wainwright currently has a “Buy” rating and a […]
